A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
KaliVir Immunotherapeutics
Ohio State University
Azienda Ospedaliero-Universitaria di Parma
St. Jude Children's Research Hospital
University of Nebraska
Azienda Ospedaliera di Padova
Medicenna Therapeutics, Inc.